miR-15a enhances the anticancer effects of cisplatin in the resistant non-small cell lung cancer cells

Platinum-based chemotherapies have long been used as a standard treatment in non-small cell lung cancer. However, cisplatin resistance is a major problem that restricts the use of cisplatin. Deregulated cell death mechanisms including apoptosis and autophagy could be responsible for the development of cisplatin resistance and miRNAs are the key regulators of these mechanisms. We aimed to analyse the effects of selected miRNAs in the development of cisplatin resistance and found that hsa-miR-15a-3p was one of the most significantly downregulated miRNAs conferring resistance to cisplatin in Calu1 epidermoid lung carcinoma cells. Only hsa-miR-15a-3p mimic transfection did not affect cell proliferation or cell death, though decreased cell viability was found when combined with cisplatin. We found that induced expression of hsa-miR-15a-3p via mimic transfection sensitised cisplatin-resistant cells to apoptosis and autophagy. Our results demonstrated that the apoptosis- and autophagy-inducing effects of hsa-miR-15a-3p might be due to suppression of BCL2, which exhibits a major connection with cell death mechanisms. This study provides new insights into the mechanism of cisplatin resistance due to silencing of the tumour suppressor hsa-miR-15a-3p and its possible contribution to apoptosis, autophagy and cisplatin resistance, which are the devil’s triangle in determining cancer cell fate.

[1]  P. Tchounwou,et al.  Cisplatin in cancer therapy: molecular mechanisms of action. , 2014, European journal of pharmacology.

[2]  John L Cleveland,et al.  Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes , 2008, Autophagy.

[3]  Y. Kondo,et al.  Radiation-induced autophagy is associated with LC3 and its inhibition sensitizes malignant glioma cells. , 2005, International journal of oncology.

[4]  Gen Sheng Wu,et al.  Role of Autophagy in Cisplatin Resistance in Ovarian Cancer Cells* , 2014, The Journal of Biological Chemistry.

[5]  T. Xia,et al.  miR-15a/16 enhances radiation sensitivity of non-small cell lung cancer cells by targeting the TLR1/NF-κB signaling pathway. , 2015, International journal of radiation oncology, biology, physics.

[6]  Rajarshi Guha,et al.  Large-scale screening identifies a novel microRNA, miR-15a-3p, which induces apoptosis in human cancer cell lines , 2013, RNA biology.

[7]  Shuwen Liu,et al.  Induction of autophagy counteracts the anticancer effect of cisplatin in human esophageal cancer cells with acquired drug resistance. , 2014, Cancer letters.

[8]  B. Arun,et al.  Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells , 2008, Autophagy.

[9]  Pınar Obakan,et al.  Roscovitine-treated HeLa cells finalize autophagy later than apoptosis by downregulating Bcl‑2. , 2015, Molecular medicine reports.

[10]  J. Duyster,et al.  The anticancer drug imatinib induces cellular autophagy , 2007, Leukemia.

[11]  S. Pattingre,et al.  Bcl-2 inhibition of autophagy: a new route to cancer? , 2006, Cancer research.

[12]  Takeshi Noda,et al.  LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing , 2000, The EMBO journal.

[13]  Chunhong Zhang,et al.  [Influence of recombinant lentiviral vector encoding miR-15a/16-1 in biological features of human nasopharyngeal carcinoma CNE-2Z cells]. , 2013, Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery.

[14]  C. Croce,et al.  Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Wei Gao,et al.  Inhibition of autophagy-potentiated chemosensitivity to cisplatin in laryngeal cancer Hep-2 cells. , 2012, American journal of otolaryngology.

[16]  F. Cecconi.  Autophagy regulation by miRNAs: when cleaning goes out of service , 2011, The EMBO journal.

[17]  W. Bursch,et al.  Autophagic and apoptotic types of programmed cell death exhibit different fates of cytoskeletal filaments. , 2000, Journal of cell science.

[18]  J. Mandl,et al.  A cellular stress-directed bistable switch controls the crosstalk between autophagy and apoptosis. , 2013, Molecular bioSystems.

[19]  T. Brunner,et al.  miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer. , 2009, Cancer research.

[20]  A. Pettitt,et al.  Loss of MIR15A and MIR16‐1 at 13q14 is associated with increased TP53 mRNA, de‐repression of BCL2 and adverse outcome in chronic lymphocytic leukaemia , 2014, British journal of haematology.

[21]  A. Sánchez-Aguilera,et al.  Cell cycle deregulation in B-cell lymphomas. , 2003, Blood.

[22]  K. O'Byrne,et al.  The emerging role of microRNAs in resistance to lung cancer treatments. , 2015, Cancer treatment reviews.

[23]  B. Liu,et al.  Oncogenic and tumor suppressive roles of microRNAs in apoptosis and autophagy , 2014, Apoptosis.

[24]  Wei Zheng,et al.  Application of real-time cell electronic sensing (RT-CES) technology to cell-based assays. , 2004, Assay and drug development technologies.

[25]  Z. Eroglu,et al.  Cisplatin resistance induced by decreased apoptotic activity in non‐small‐cell lung cancer cell lines , 2012, Cell biology international.

[26]  C. Croce,et al.  miR-15a and miR-16-1 in cancer: discovery, function and future perspectives , 2010, Cell Death and Differentiation.

[27]  H. Zentgraf,et al.  Autophagy—A double‐edged sword in oncology , 2009, International journal of cancer.

[28]  Wupeng,et al.  Influence of Recombinant Lentiviral Vector Encoding miR-15a/16-1 in Biological Features of Human Nasopharyngeal Carcinoma CNE-2Z Cells , 2014 .

[29]  C. Croce,et al.  miR-15 and miR-16 induce apoptosis by targeting BCL2. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[30]  D. Vaux,et al.  BCL2 and related prosurvival proteins require BAK1 and BAX to affect autophagy , 2014, Autophagy.

[31]  Lei Jiang,et al.  miR-15a/16-1 enhances retinoic acid-mediated differentiation of leukemic cells and is up-regulated by retinoic acid , 2011, Leukemia & lymphoma.

[32]  C. Reynolds,et al.  Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy , 2009, Clinical Cancer Research.

[33]  D. Klionsky,et al.  Eaten alive: a history of macroautophagy , 2010, Nature Cell Biology.

[34]  Young-Jun Jeon,et al.  MicroRNAs in lung cancer. , 2014, World journal of methodology.

[35]  J. Debnath,et al.  Autophagy and tumorigenesis , 2010, FEBS letters.

[36]  Jun-jie Chen,et al.  Histone deacetylases inhibitor trichostatin A increases the expression of Dleu2/miR-15a/16-1 via HDAC3 in non-small cell lung cancer , 2013, Molecular and Cellular Biochemistry.

[37]  P. Chanvorachote,et al.  Long-term cisplatin exposure impairs autophagy and causes cisplatin resistance in human lung cancer cells , 2012, Molecular and Cellular Biochemistry.

[38]  Elham Tafsiri,et al.  Expression of miRNAs in non-small-cell lung carcinomas and their association with clinicopathological features , 2015, Tumor Biology.

[39]  Bo Liu,et al.  MicroRNA-modulated autophagic signaling networks in cancer. , 2012, The international journal of biochemistry & cell biology.

[40]  H. Fan,et al.  MiR-15a-16 represses Cripto and inhibits NSCLC cell progression , 2014, Molecular and Cellular Biochemistry.

[41]  Donna D. Zhang,et al.  Induction of autophagy contributes to cisplatin resistance in human ovarian cancer cells , 2014, Molecular medicine reports.

[42]  Jun O. Liu,et al.  Post-translational Modifications of Three Members of the Human MAP1LC3 Family and Detection of a Novel Type of Modification for MAP1LC3B* , 2003, Journal of Biological Chemistry.